Advertisement

Organisation › Details
Owkin (FR)
Owkin is the first end-to-end TechBio company on a mission to understand complex biology and derive new multimodal biomarkers through AI. We identify precision therapeutics, de-risk and accelerate clinical trials and develop diagnostics using AI trained on world-class patient data through privacy-enhancing federated technologies. We merge wet lab experiments with advanced AI techniques to create a powerful feedback loop for accelerated discovery and innovation in oncology, cardiovascular, immunity and inflammation. Owkin also founded MOSAIC, the world’s largest spatial multi-omics atlas for cancer research. Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like Fidelity, GV and Bpifrance, among others. *
![]() |
Start | 2018-01-17 existent |
Group | Owkin (Group) | |
![]() |
Industry | artificial intelligence (AI) / machine learning (ML) |
Industry 2 | Owkin Socrates | |
![]() |
Person | Clozel, Thomas (Owkin 202111 CEO + Co-Founder) |
Person 2 | Strigini, Bruno (Novartis 201605–201801 Head Oncology Business Unit RETIRED 1/18 joined 2014 from Merck & Co) | |
![]() |
Region | Paris |
Country | France | |
Street | 12 Rue Martel | |
City | 75010 Paris | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology". | ||
Record changed: 2024-05-24 |
Advertisement

More documents for Owkin (Group)
- [1] Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology"....
- [2] Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris....
- [3] Owkin. (12/19/23). "Press Release: Owkin Enters Collaboration Agreement with MSD to Develop AI-powered Diagnostics for Cancer"....
- [4] Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra"....
- [5] Owkin. (10/17/23). "Press Release: Servier Partners with Owkin with the Aim of Discovering and Developing AI-driven Precision Therapeutics"....
- [6] Owkin. (10/4/22). "Press Release: Owkin Appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer"....
- [7] Owkin. (9/13/22). "Press Release: Owkin and 12 Partners Launch $14 Million NIH Project to Allow Doctors to Spot Cancer, Depression and other Diseases from the Human Voice"....
- [8] Sanofi S.A.. (11/18/21). "Press Release: Sanofi Invests $180 Million Equity in Owkin’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline". Paris....
- [9] Owkin. (12/2/19). "Press Release: Owkin Teams up with Nvidia and King's College London to Deliver AI to Hospitals While Protecting Patient Data With Federated Learning". Paris & New York....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top